Cyclotraxin B

Cyclotraxin B (CTX-B) is a small (1200 Da) cyclic peptide and highly potent (IC 50 = 0.30 nM), selective, and non-competitive antagonist or negative allosteric modulator of TrkB, the main receptor of brain-derived neurotrophic factor…

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cyclotraxin B (CTX-B) is a small (1200 Da) cyclic peptide and highly potent (IC 50 = 0.30 nM), selective, and non-competitive antagonist or negative allosteric modulator of TrkB, the main receptor of brain-derived neurotrophic factor (BDNF). CTX-B was originally developed by Cazorla M. and colleagues at Université Paris and Inserm in 2010, mimicking a specific structural loop in BDNF known for its functional selectivity.

Cyclotraxin-B's name originates from Cyclic trk inhibitor B. CTX-B crosses the blood-brain-barrier with systemic administration and produces anxiolytic-like effects in animals, though notably not antidepressant-like effects. The compound has also been found to produce analgesic effects in animal models of neuropathic pain.

In addition to TrkB, CTX-B has been found to be an allosteric modulator of VEGFR2, one of the receptors of vascular endothelial growth factor (VEGF).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1329038706 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001329038706 · captured 2025-12-23 · ledger · version history

Cite this page as: encyclopegia.org, “Cyclotraxin B”, snapshot enwiki-001329038706. https://encyclopegia.org/a/cyclotraxin-b

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.